Genetic knockdown and pharmacological inhibition of CPS1 significantly reduced the tumor burden and metastasis in mice with the spontaneous (KrasG12D/+; p53-/-) and induced metastatic lung cancer. The gene discussed is CPS1; the disease is neoplasm.